Literature DB >> 5316407

Pharmacokinetics and biological effects of nortriptyline in man.

F Sjöqvist, B Alexanderson, M Asberg, L Bertilsson, O Borgå, B Hamberger, D Tuck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5316407     DOI: 10.1111/j.1600-0773.1971.tb03306.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


× No keyword cloud information.
  12 in total

1.  The effect of fluphenazine on steady state plasma levels of nortriptyline.

Authors:  I H Stevenson; A A Schiff
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

2.  [Methodology of therapeutic trials in psychopharmacology (author's transl)].

Authors:  P Pichot
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1975-12-22

3.  Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain.

Authors:  R Ohman; M Larsson; I M Nilsson; J Engel; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

4.  Prediction of steady-state plasma levels of nortriptyline from single oral dose kinetics: a study in twins.

Authors:  B Alexanderson
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

5.  Effect of route of administration on drug disposition.

Authors:  S Riegelman; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

6.  Pharmacokinetic aspects of protriptyline plasma levels.

Authors:  J P Moody; S F Whyte; A J MacDonald; G J Naylor
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

7.  Assessment of drugs in schizophrenia. Discussion on basic trial design.

Authors:  A Coppen
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

8.  Prediction of steady-state nortriptyline plasma levels by the repeated one-point method.

Authors:  W K Fant; W A Ritschel; S K Alwis; S Roe; J Ehret
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

9.  Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolites.

Authors:  B Vandel; M Sandoz; S Vandel; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Pharmacokinetics of nomifensine in impaired renal function.

Authors:  S Ringoir; N Lameire; M Munche; W Heptner; K Taeuber
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.